losartan has been researched along with Kidney Stones in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, B | 1 |
| Wang, Q | 1 |
| Lu, Y | 1 |
| Li, C | 1 |
| Hu, H | 1 |
| Zhang, J | 1 |
| Wang, Y | 1 |
| Zhu, J | 1 |
| Zhu, Y | 1 |
| Xun, Y | 1 |
| Wang, S | 1 |
1 other study available for losartan and Kidney Stones
| Article | Year |
|---|---|
Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress.
Topics: Animals; Antihypertensive Agents; Calcium Oxalate; Humans; Kidney; Kidney Calculi; Losartan; Male; N | 2018 |